Similarly, the enrichment of FGFR3 mutations in salivary gland tumors and ERBB4 mutations in thyroid cancers among Asian patients suggests that clinical investigations targeting these alterations need to target demographically diverse patient communities. Here, ERBB4 is linked to thyroid cancer.